trans-rhaponticin

Term ID

CHEBI:8824

Synonyms

(2S,3R,4S,5S,6R)-2-{3-hydroxy-5-[(E)-2-(3-hydroxy-4-methoxyphenyl)ethenyl]phenoxy}-6-(hydroxymethyl)oxane-3,4,5-triol
(2S,3R,4S,5S,6R)-2-{3-hydroxy-5-[(E)-2-(3-hydroxy-4-methoxyphenyl)ethenyl]phenoxy}-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol
(E)-rhaponticin
3-hydroxy-5-[(E)-2-(3-hydroxy-4-methoxyphenyl)ethenyl]phenyl beta-D-glucopyranoside
ponticin
rhaponticin
rhaponticine
rhapontin

Definition

A rhaponticin in which the double bond adopts a trans-configuration. It possesses a range of pharmacological activities including antitumour, antiinflammatory, antilipemic and neuroprotective activities.

References

agr:IND44126010
cas:155-58-8
foodb.food:FDB008525
kegg.compound:C10288
knapsack:C00002904
lipidmaps:LMPK13090002
pubmed:19235684
pubmed:21782194
pubmed:22121779
pubmed:22452262
pubmed:23220535
pubmed:23364836
pubmed:23421127
pubmed:24362821
pubmed:25127020
pubmed:26598549
pubmed:27930969
pubmed:28364627
pubmed:30015877
pubmed:30666906
pubmed:31095470
pubmed:31108853
pubmed:32662907
pubmed:32926752
pubmed:33088192
pubmed:33494167
pubmed:33605003
pubmed:33770502
pubmed:7362262
wikipedia.en:Rhaponticin

Ontology

ChEBI ( EBI )

Resources

CTD

Relationships

Phenotype

Phenotype resulting from trans-rhaponticin

Phenotype where environments contain trans-rhaponticin

Phenotype modified by environments containing trans-rhaponticin

Phenotype affecting trans-rhaponticin

Human Disease Model